Motus GI Holdings (NASDAQ:MOTS) – Research analysts at Piper Jaffray issued their Q2 2018 earnings per share estimates for shares of Motus GI in a report issued on Tuesday, May 15th. Piper Jaffray analyst M. O’brien forecasts that the company will post earnings per share of ($0.27) for the quarter. Piper Jaffray currently has a “Overweight” rating and a $7.00 target price on the stock. Piper Jaffray also issued estimates for Motus GI’s Q3 2018 earnings at ($0.27) EPS, Q4 2018 earnings at ($0.27) EPS, FY2018 earnings at ($1.12) EPS, Q1 2019 earnings at ($0.32) EPS, Q2 2019 earnings at ($0.27) EPS, Q3 2019 earnings at ($0.22) EPS, Q4 2019 earnings at ($0.13) EPS and FY2019 earnings at ($0.88) EPS.
MOTS has been the topic of a number of other reports. ValuEngine upgraded shares of Motus GI from a “sell” rating to a “hold” rating in a report on Wednesday, May 2nd. Oppenheimer began coverage on shares of Motus GI in a report on Monday, March 12th. They issued an “outperform” rating and a $7.00 price objective on the stock.
An institutional investor recently bought a new position in Motus GI stock. Hilltop Holdings Inc. acquired a new stake in Motus GI Holdings (NASDAQ:MOTS) during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 112,100 shares of the company’s stock, valued at approximately $502,000. Hilltop Holdings Inc. owned about 0.72% of Motus GI as of its most recent SEC filing. Institutional investors and hedge funds own 0.01% of the company’s stock.
Motus GI Company Profile
Motus GI Holdings, Inc, a medical technology company, focuses on the development and commercialization of the Pure-Vu System. Its Pure-Vu System is designed to improve the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon.
Receive News & Ratings for Motus GI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Motus GI and related companies with MarketBeat.com's FREE daily email newsletter.